Immunogen, Inc. (IMGN) Posts Narrower than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q2 EPS of ($0.17), $0.06 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $5.43 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS says bull market has further to run
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
- Premarket movers: Crypto stocks rally, Ross Stores jump on upbeat forecast
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
